REDCARE PHARMACY NV (RDC.DE) Stock Price, Forecast & Analysis

FRA:RDC • NL0012044747

60.65 EUR
+0.1 (+0.17%)
Last: Feb 27, 2026, 07:00 PM

RDC.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap1.25B
Revenue(TTM)2.82B
Net Income(TTM)-35.19M
Shares20.58M
Float15.16M
52 Week High144.4
52 Week Low55.8
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-1.75
PEN/A
Fwd PE306.03
Earnings (Next)03-04
IPO2016-10-13
Sector
GICS SectorConsumer Staples
GICS IndustryConsumer Staples Distribution & Retail
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS SubIndustryDrug Retail
RDC.DE short term performance overview.The bars show the price performance of RDC.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

RDC.DE long term performance overview.The bars show the price performance of RDC.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of RDC.DE is 60.65 EUR. In the past month the price decreased by -3.04%. In the past year, price decreased by -48.12%.

REDCARE PHARMACY NV / RDC Daily stock chart

RDC.DE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
RDC.DE Full Technical Analysis Report

RDC.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to RDC.DE. RDC.DE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
RDC.DE Full Fundamental Analysis Report

RDC.DE Financial Highlights

Over the last trailing twelve months RDC.DE reported a non-GAAP Earnings per Share(EPS) of -1.75. The EPS decreased by -39.61% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -2.88%
ROE -7.01%
Debt/Equity 0.62
Chartmill High Growth Momentum
EPS Q2Q%-2.86%
Sales Q2Q%25.18%
EPS 1Y (TTM)-39.61%
Revenue 1Y (TTM)26.68%
RDC.DE financials

RDC.DE Forecast & Estimates

16 analysts have analysed RDC.DE and the average price target is 131.3 EUR. This implies a price increase of 116.49% is expected in the next year compared to the current price of 60.65.

For the next year, analysts expect an EPS growth of 48.65% and a revenue growth 24.2% for RDC.DE


Analysts
Analysts80
Price Target131.3 (116.49%)
EPS Next Y48.65%
Revenue Next Year24.2%
RDC.DE Analyst EstimatesRDC.DE Analyst Ratings

RDC.DE Ownership

Ownership
Inst Owners51.62%
Ins Owners7.32%
Short Float %N/A
Short RatioN/A
RDC.DE Ownership

About RDC.DE

Company Profile

RDC logo image Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. The company is headquartered in Sevenum, Limburg and currently employs 2,659 full-time employees. The company went IPO on 2016-10-13. The firm focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The firm is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.

Company Info

REDCARE PHARMACY NV

Erik de Rodeweg 11/13

Sevenum LIMBURG NL

Employees: 1827

RDC Company Website

RDC Investor Relations

REDCARE PHARMACY NV / RDC.DE FAQ

What does REDCARE PHARMACY NV do?

Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. The company is headquartered in Sevenum, Limburg and currently employs 2,659 full-time employees. The company went IPO on 2016-10-13. The firm focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The firm is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.


Can you provide the latest stock price for REDCARE PHARMACY NV?

The current stock price of RDC.DE is 60.65 EUR. The price increased by 0.17% in the last trading session.


What is the dividend status of REDCARE PHARMACY NV?

RDC.DE does not pay a dividend.


What is the ChartMill rating of REDCARE PHARMACY NV stock?

RDC.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the analyst forecast for RDC.DE stock?

16 analysts have analysed RDC.DE and the average price target is 131.3 EUR. This implies a price increase of 116.49% is expected in the next year compared to the current price of 60.65.


Should I buy RDC stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on RDC.DE.


What is the market capitalization of RDC stock?

REDCARE PHARMACY NV (RDC.DE) has a market capitalization of 1.25B EUR. This makes RDC.DE a Small Cap stock.